Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia. [electronic resource]
Producer: 20111128Description: 182-9 p. digitalISSN:- 1365-2141
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Chemical and Drug Induced Liver Injury -- etiology
- Cytarabine -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Humans
- Infections -- etiology
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Proportional Hazards Models
- Recurrence
- Remission Induction
- Risk
- Salvage Therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.